Since the discovery that telomerase is repressed in most
normal human somatic cells but strongly expressed in most human tumors, telomerase has become a target for therapeutic agents to combat human cancer.
The strict limit in proliferative potential of
normal human somatic cells - a process known as replicative senescence - is highly relevant to the immune system, because clonal expansion is fundamental to adaptive immunity.
Not exact matches
seek to identify the mutational processes underlying mutational signatures found in cancers, characterise the mutational processes operating in
normal cells, use phylogenetic analyses of
somatic mutations in
humans to explore cellular lineages during embryonic development